KCK LTD.

In its 13F for Q3 2025 (holdings as of September 30, 2025, filed October 14, 2025), KCK LTD. reported 2 stock positions worth $15.1 million. Its top holding was Sight Sciences (SGHT) at 99.7% of the portfolio, followed by Rein Therapeutics (RNTX, 0.3%). Its holdings were unchanged from Q2 2025.

Most Recent 13F
Q3 2025
Location
HAMILTON, D0
CIK
0001657662
Portfolio Value
$15.1M (Q3 2025)
SEC Filing
0001657662-25-000015 ↗ filed Oct 14, 2025

Holdings Value

0$20.0M$40.0M$60.0M$80.0M Q4 2024: $75.0M Q4 2024 Q1 2025: $10.5M Q1 2025 Q2 2025: $18.3M Q2 2025 Q3 2025: $15.1M $15.1M Q3 2025

Holdings 2 stocks · $15.1M
SGHT Sight Sciences Inc. 99.66% 4,374,975 $15.0M No change
RNTX Rein Therapeutics Inc. 0.34% 22,341 $52K No change

Portfolio Sells Q2 2025 → Q3 2025
None this quarter.

Portfolio Buys Q2 2025 → Q3 2025
None this quarter.

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q3 2025 2$15.1MSGHT, RNTX
Q2 2025 2$18.3MSGHT, RNTX
Q1 2025 2$10.5MSGHT, RNTX
Q4 2024 3$75.0MNPCE, SGHT, RNTX